Merck
MRK
#43
Rank
$291.98 B
Marketcap
$118.10
Share price
-1.28%
Change (1 day)
32.89%
Change (1 year)

Operating Margin for Merck (MRK)

Operating Margin as of March 2026 (TTM): 32.40%

According to Merck's latest financial reports and stock price the company's current Operating Margin is 32.40%. At the end of 2025 the company had an Operating Margin of 32.41%.

Operating Margin history for Merck from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202532.41%4.3%
202431.07%888.71%
20233.14%-88.67%
202227.74%-2.66%
202128.50%101.79%
202014.12%-22.96%
201918.33%-10.9%
201820.57%26.58%
201716.25%38.87%
201611.70%-14.41%
201513.67%-66.58%
201440.92%224.94%
201312.59%-31.89%
201218.49%21.12%
201115.26%324.66%
20103.59%-93.55%
200955.75%33.88%
200841.64%198.92%
200713.93%-49.32%
200627.48%-17.84%
200533.45%-3.97%
200434.84%-13.46%
200340.25%-10.56%
200245.01%-4.1%
200146.93%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58% 6.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
28.85%-10.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
12.01%-62.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
19.09%-41.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
39.47% 21.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
24.42%-24.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
13.21%-59.23%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
19.35%-40.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
22.60%-30.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
7.08%-78.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.